AMENDMENT NO. 1 TO MASTER SPONSORED RESEARCH AGREEMENTMaster Sponsored Research Agreement • November 12th, 2019 • IVERIC Bio, Inc. • Pharmaceutical preparations
This Amendment No. 1 to the Master Sponsored Research Agreement (“Agreement”) by and between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (“Penn”), with offices located at Penn Center for Innovation, 3600 Civic Center Blvd., 9th Floor, Philadelphia, PA 19104-4310, and IVERIC bio, Inc. (formerly Ophthotech Corporation), a Delaware corporation (“Sponsor”), having a place of business at One Penn Plaza, Suite 3520, New York, NY 10119 is dated as of October 1, 2019 (the “Amendment No. 1 Effective Date”). Penn and Sponsor may be referred to herein as a “Party” or, collectively, as “Parties”.
Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions. MASTER SPONSORED RESEARCH...Master Sponsored Research Agreement • August 1st, 2019 • IVERIC Bio, Inc. • Pharmaceutical preparations • Pennsylvania
This Master Sponsored Research Agreement (“Agreement”) is dated as of October 30, 2018 (the “Effective Date”) by and between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (“Penn”), with offices located at Penn Center for Innovation, 3160 Chestnut Street, Suite 200, Philadelphia, PA 19104-6283, and Ophthotech Corporation, a Delaware corporation (“Sponsor”), having a place of business at One Penn Plaza, Suite 3520, New York, NY 10119. Penn and Sponsor may be referred to herein as a “Party” or, collectively, as “Parties”.
Master Sponsored Research Agreement – What To Expect . . .Master Sponsored Research Agreement • December 18th, 2017
A master sponsored research agreement (Master) is used to facilitate a long-term strategic relationship with a company that funds ISU research on a frequent basis by streamlining the negotiation process. The approved terms are applied to every project performed under the Master without the need to negotiate. Individual projects are implemented through a project exhibit sometimes referenced by ISU as “Exhibit A.”
MASTER SPONSORED RESEARCH AGREEMENTMaster Sponsored Research Agreement • March 16th, 2022 • North Dakota
This Sponsored Research Agreement (“Agreement”) is entered into by and between North Dakota State University, Fargo, North Dakota (“NDSU”) and , a corporation having a place of business at (“Sponsor”).
MASTER SPONSORED RESEARCH AGREEMENTMaster Sponsored Research Agreement • March 25th, 2008 • Neurologix Inc/De • Pharmaceutical preparations • Ohio
This Research Agreement ( “Agreement”) is made as of this May 10, 2006 (the “Effective Date”) by and between The Ohio State University Research Foundation, on behalf of Ohio State University, a university with a principal place of business at 1960 Kenny Road, Columbus, OH 43210 (“Institution”) and Neurologix, Inc., a corporation with a principal place of business at One Bridge Plaza, Ft. Lee, New Jersey, USA 07024 (“Sponsor”).
MASTER SPONSORED RESEARCH AGREEMENTMaster Sponsored Research Agreement • August 8th, 2023 • Immunome Inc. • Pharmaceutical preparations • Indiana
This Master Sponsored Research Agreement (“Agreement”), made as of February 1, 2022 (“Effective Date”), by and among MorphImmune, Inc (“COMPANY” or “Sponsor” or “Company”), a corporation having its principal place of business at 1281 Win Hentschel Blvd. Suite 1300, West Lafayette, IN 47906; Purdue Research Foundation (“PRF”) 1281 Win Hentschel Blvd., West Lafayette, Indiana 47906; and Purdue University (“Purdue” or “University”), 610 Purdue Mall, West Lafayette, Indiana 47907-2040, (each a “Party” and collectively, the “Parties”).
THIRD AMENDMENT TO MASTER SPONSORED RESEARCH AGREEMENTMaster Sponsored Research Agreement • September 24th, 2009 • Neurologix Inc/De • Pharmaceutical preparations • Ohio
This Third Amendment, dated as of September 24, 2009 (this “Third Amendment”), by and between THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION, on behalf of Ohio State University, a university with a principal place of business at 1960 Kenny Road, Columbus, OH 43210 (“Institution”), and NEUROLOGIX, INC., a Delaware corporation with a principal place of business at One Bridge Plaza, Fort Lee, New Jersey, 07024 (“Sponsor”).
SECOND AMENDMENT TO MASTER SPONSORED RESEARCH AGREEMENTMaster Sponsored Research Agreement • December 16th, 2008 • Neurologix Inc/De • Pharmaceutical preparations • Ohio
This Second Amendment, dated as of October 29, 2008 (this “Second Amendment”), by and between THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION, on behalf of Ohio State University, a university with a principal place of business at 1960 Kenny Road, Columbus, OH 43210 (“Institution”), and NEUROLOGIX, INC., a Delaware corporation with a principal place of business at One Bridge Plaza, Fort Lee, New Jersey, 07024 (“Sponsor”).
AMENDMENT NO. 2 TO MASTER SPONSORED RESEARCH AGREEMENTMaster Sponsored Research Agreement • August 4th, 2021 • IVERIC Bio, Inc. • Pharmaceutical preparations
This Amendment No. 2 to the Master Sponsored Research Agreement (“Amendment No. 2”) by and between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (“Penn”), with offices located at Penn Center for Innovation, 3600 Civic Center Blvd., 9th Floor, Philadelphia, PA 19104-4310, and IVERIC bio Gene Therapy LLC (successor-in-interest to IVERIC bio, Inc., One Penn Plaza, Suite 3520, New York, NY 10119.), a Delaware limited liability company (“Sponsor”), having a place of business at Five Penn Plaza, Suite 2372, New York, NY 10001 is dated as of May 18, 2021 (the “Amendment No. 2 Effective Date”). Penn and Sponsor may be referred to herein as a “Party” or, collectively, as “Parties”.
FOURTH AMENDMENT TO MASTER SPONSORED RESEARCH AGREEMENTMaster Sponsored Research Agreement • January 20th, 2011 • Neurologix Inc/De • Pharmaceutical preparations • Ohio
This Fourth Amendment, dated as of January 18, 2011 (this “Fourth Amendment”), by and between THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION, on behalf of Ohio State University, a university with a principal place of business at 1960 Kenny Road, Columbus, OH 43210 (“Institution”), and NEUROLOGIX, INC., a Delaware corporation with a principal place of business at One Bridge Plaza, Fort Lee, New Jersey, 07024 (“Sponsor”).
MASTER SPONSORED RESEARCH AGREEMENTMaster Sponsored Research Agreement • October 8th, 2020 • Y-mAbs Therapeutics, Inc. • Pharmaceutical preparations • New York
This Master Sponsored Research Agreement (this “Agreement”), effective as of the date of the last signature below (“Effective Date”), is by and between Memorial Sloan Kettering Cancer Center, a New York not-for-profit entity, with offices at 1275 York Avenue, New York, NY 10065 (“MSK”) and Y-mAbs Therapeutics, Inc., a Delaware corporation with a principal office at 230 Park Avenue, Suite 3350, New York, New York 10169 (“Sponsor”). MSK and Sponsor may be individually referred to as a “Party”, and collectively as the “Parties”.
AMENDMENT TO MASTER SPONSORED RESEARCH AGREEMENTMaster Sponsored Research Agreement • June 11th, 2008 • Neurologix Inc/De • Pharmaceutical preparations • Ohio
Amendment, dated as of May 29th, 2008 (this “Amendment”), by and between THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION, on behalf of Ohio State University, a university with a principal place of business at 1960 Kenny Road, Columbus, OH 43210 (“Institution”), and NEUROLOGIX, INC., a Delaware corporation with a principal place of business at One Bridge Plaza, Fort Lee, New Jersey, 07024 (“Sponsor”).
MASTER SPONSORED RESEARCH AGREEMENTMaster Sponsored Research Agreement • October 9th, 2015 • Wave Life Sciences Pte LTD • Pharmaceutical preparations • Pennsylvania
THIS MASTER SPONSORED RESEARCH AGREEMENT (“Master Agreement”) is made and effective as of April 1, 2015 (the “Effective Date”), by and between WaVe Life Sciences PTE, Ltd with an office at 419 Western Avenue, Boston, Massachusetts, 02135 (“WaVe”), and The Children’s Hospital of Philadelphia, a Pennsylvania non-profit corporation with an office at 34th Street and Civic Center, Philadelphia, Pennsylvania 19104 (together with its affiliates “CHOP”). WaVe and CHOP are each hereafter referred to individually as a “Party” and together as the “Parties.”
